Simplex Trading
ORTX

Simplex Trading’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Simplex Trading’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,200
Closed -$19K – 10302
2023
Q4 		$19K Buy
+1,200
New +$18.9K ﹤0.01% 6980
2022
Q1 		– Sell
-1,540
Closed -$20K – 11675
2021
Q4 		$20K Sell
1,540
-8,280
-84% -$137K ﹤0.01% 8377
2021
Q3 		$421K Buy
9,820
+40
+0.4% +$1.19K ﹤0.01% 4355
2021
Q2 		$429K Buy
9,780
+9,729
+19,076% +$542K ﹤0.01% 4402
2021
Q1 		$370K Buy
51
+50
+5,000% +$3.55K ﹤0.01% 3841
2020
Q4 		$4K Buy
+1
New +$45 ﹤0.01% 7830
2020
Q3 		– Hold
0
– – – 7624

Simplex Trading's ORTX Position: Q4 2022 in Review

Simplex Trading sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2022, closing a stake of 187 shares — an estimated $827 sold.

Simplex Trading first reported a position in ORTX in Q2 2020 and held it in 9 quarters. The position peaked at $259K in Q2 2021. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2022.

  • Simplex Trading reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 187 Orchard Therapeutics plc American Depositary Shares shares in Q4 2022, an estimated $827.
  • Simplex Trading first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2020 and held it in 9 quarters.
  • Simplex Trading's Orchard Therapeutics plc American Depositary Shares position peaked at $259K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.